Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial

Ulcerative colitis

Ungaro, R. C., Mehandru, S., Allen, P. B., Peyrin‐Biroulet, L., & Colombel, J. (2016) · The Lancet · doi:10.1016/s0140-6736(16)32126-2 · Cited by 3,659

The role of short chain fatty acids in health and disease

Tan, J., McKenzie, C., Potamitis, M., Thorburn, A. N., Mackay, C. R., & Macia, L. (2014) · Advances in immunology · doi:10.1016/b978-0-12-800100-4.00003-9 · Cited by 2,425

Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice

Devkota, S., Wang, Y., Musch, M. W., Leone, V., Fehlner-Peach, H., Nadimpalli, A., Antonopoulos, D. A., Jabri, B., & Chang, E. B. (2012) · Nature · doi:10.1038/nature11225 · Cited by 1,904

Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial

Moayyedi, P., Surette, M. G., Kim, P. T., Libertucci, J., Wolfe, M., Onischi, C., Armstrong, D., Marshall, J. K., Kassam, Z., Reinisch, W., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.001 · Cited by 1,499

Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial

Paramsothy, S., Kamm, M. A., Kaakoush, N. O., Walsh, A. J., van den Bogaerde, J., Samuel, D., Leong, R. W. L., Connor, S., Ng, W., Paramsothy, R., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30182-4 · Cited by 1,276

Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management

Harbord, M., Eliakim, R., Bettenworth, D., Karmiris, K., Katsanos, K., Kopylov, U., Kucharzik, T., Molnár, T., Raine, T., Sebastian, S., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx009 · Cited by 1,180

Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis

Rossen, N. G., Fuentes, S., van der Spek, M. J., Tijssen, J. G., Hartman, J. H. A., Duflou, A., Löwenberg, M., van den Brink, G. R., Mathus-Vliegen, E. M. H., de Vos, W. M., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.045 · Cited by 921

Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis

Costello, S. P., Hughes, P. A., Waters, O., Bryant, R. V., Vincent, A. D., Blatchford, P. A., Katsikeros, R., Makanyanga, J. C., Campaniello, M. A., Mavrangelos, C., et al. (2019) · JAMA · doi:10.1001/jama.2018.20046 · Cited by 895

Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation

Chassaing, B., Van de Wiele, T., De Bodt, J., Marzorati, M., & Gewirtz, A. T. (2017) · Gut · doi:10.1136/gutjnl-2016-313099 · Cited by 590

Review article: insights into colonic protein fermentation, its modulation and potential health implications

Yao, C. K., Muir, J. G., & Gibson, P. R. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13456 · Cited by 441

Natural killer cells in antitumour adoptive cell immunotherapy

Laskowski, T. J., Biederstädt, A., & Rezvani, K. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00491-0 · Cited by 810

Gut-Microbiota-Derived Metabolites Maintain Gut and Systemic Immune Homeostasis

Wang, J., Zhu, N., Su, L., Gao, Y., & Yang, R. (2023) · Cells · doi:10.3390/cells12050793 · Cited by 649

Fecal microbiota transplantation: current challenges and future landscapes

Yadegar, A., Bar‐Yoseph, H., Monaghan, T. M., Pakpour, S., Severino, A., Kuijper, E. J., Smits, W. K., Terveer, E. M., Neupane, S., Nabavi-Rad, A., et al. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00060-22 · Cited by 397

Key determinants of success in fecal microbiota transplantation: From microbiome to clinic

Porcari, S., Benech, N., Valles-Colomer, M., Segata, N., Gasbarrini, A., Cammarota, G., Sokol, H., & Ianiro, G. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.03.020 · Cited by 331

Inflammation and malnutrition in inflammatory bowel disease

Massironi, S., Viganò, C., Palermo, A., Pirola, L., Mulinacci, G., Allocca, M., Peyrin‐Biroulet, L., & Danese, S. (2023) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(23)00011-0 · Cited by 320

The gut commensal Blautia maintains colonic mucus function under low-fiber consumption through secretion of short-chain fatty acids

Holmberg, S. M., Feeney, R. H., K., V., Puértolas-Balint, F., Singh, D. K., Wongkuna, S., Zandbergen, L. M., Hauner, H., Brandl, B., Nieminen, A. I., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47594-w · Cited by 262

Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities

Iliev, I. D., Ananthakrishnan, A. N., & Guo, C.-J. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01163-0 · Cited by 249

The role of diet in shaping human gut microbiota

Rinninella, E., Tohumcu, E., Raoul, P. C., Fiorani, M., Cintoni, M., Mele, M. C., Cammarota, G., Gasbarrini, A., & Ianiro, G. (2023) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2023.101828 · Cited by 257

Western diets and chronic diseases

Adolph, T. E., & Tilg, H. (2024) · Nature Medicine · doi:10.1038/s41591-024-03165-6 · Cited by 224

The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease

Lopetuso, L. R., Deleu, S., Godny, L., Petito, V., Puca, P., Facciotti, F., Sokol, H., Ianiro, G., Masucci, L., Abreu, M., et al. (2023) · Gut · doi:10.1136/gutjnl-2023-329948 · Cited by 129

Microbiota–gut–brain axis in neurodegenerative diseases: molecular mechanisms and therapeutic targets

Chen, C., Wang, G., Li, D., & Zhang, F. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00307-1 · Cited by 133

Fecal transplantation for treatment of inflammatory bowel disease

Imdad, A., Pandit, N. G., Zaman, M., Minkoff, N. Z., Tanner‐Smith, E. E., Gomez-Duarte, O. G., Acra, S. A., & Nicholson, M. R. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012774.pub3 · Cited by 103

Efficacy and safety of fecal microbiota transplantation in the treatment of ulcerative colitis: a systematic review and meta-analysis

Feng, J. Q., Chen, Y., Liu, Y., Lin, L., Lin, X., Gong, W., Xia, R., He, J., Sheng, J., Cai, H., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-41182-6 · Cited by 93

Advances in Fecal Microbiota Transplantation for Gut Dysbiosis‐Related Diseases

Hou, S., Yu, J., Li, Y., Zhao, D., & Zhang, Z. (2025) · Advanced Science · doi:10.1002/advs.202413197 · Cited by 97

Microbiota therapeutics for inflammatory bowel disease: the way forward

Bethlehem, L., Estevinho, M. M., Grinspan, A. M., Magro, F., Faith, J. J., & Colombel, J. (2024) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(23)00441-7 · Cited by 85

From chaos to order: optimizing fecal microbiota transplantation for enhanced immune checkpoint inhibitors efficacy

Lin, A., Jiang, A., Huang, L., Yu, H., Zhang, C., Zhu, L., Mou, W., Liu, Z., Zhang, J., Cheng, Q., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2452277 · Cited by 74

Implications of gut microbiota-mediated epigenetic modifications in intestinal diseases

Zhang, Q., Liu, Y., Li, Y., Bai, G., Pang, J., Wu, M., Li, J., Zhao, X., & Xia, Y. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2508426 · Cited by 73

Gut microbiota dysbiosis in inflammatory bowel disease: interaction with intestinal barriers and microbiota-targeted treatment options

Xie, H., Yu, S. B., Tang, M., Xun, Y., Shen, Q., & Wu, G. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1608025 · Cited by 78

Heavy arch: from inflammatory bowel diseases to metabolic disorders

Adolph, T. E., Meyer, M., Jukic, A., & Tilg, H. (2024) · Gut · doi:10.1136/gutjnl-2024-331914 · Cited by 72

Unraveling the Impact of Gut and Oral Microbiome on Gut Health in Inflammatory Bowel Diseases

Elzayat, H., Mesto, G., & Al-Marzooq, F. I. (2023) · Nutrients · doi:10.3390/nu15153377 · Cited by 66

Regulatory roles of intestinal CD4 + T cells in inflammation and their modulation by the intestinal microbiota

Ma, Z., Wang, Z., Cao, J., Dong, Y., & Chen, Y. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2560019 · Cited by 70

Unveiling the potential of selenium-enriched tea: Compositional profiles, physiological activities, and health benefits

Wang, K., Fang, Q.-T., He, P., Tu, Y., Liu, Z., & Li, B. (2024) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2024.104356 · Cited by 58

Precision microbiota therapy for IBD: premise and promise

Nagayama, M., Gogokhia, L., & Longman, R. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2489067 · Cited by 58

Fecal microbiota transplantation in clinical practice: Present controversies and future prospects

Tian, H., Wang, X., Fang, Z., Li, L., Wu, C., Bi, D., Li, N., Chen, Q., & Qin, H. (2024) · hLife · doi:10.1016/j.hlife.2024.01.006 · Cited by 56

Fecal Microbiota Transplantation Across the Lifespan: Balancing Efficacy, Safety, and Innovation

Gulati, A., Nicholson, M. R., Khoruts, A., & Kahn, S. A. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002167 · Cited by 55

The Role of the Microbiome in the Pathogenesis and Treatment of Ulcerative Colitis—A Literature Review

Świrkosz, G., Szczygieł, A., Logoń, K., Wrześniewska, M., & Gomułka, K. (2023) · Biomedicines · doi:10.3390/biomedicines11123144 · Cited by 56

The Role of Fecal Microbiota Transplantation in IBD

Fanizzi, F., D’Amico, F., Bombassaro, I., Zilli, A., Furfaro, F., Parigi, T. L., Cicerone, C., Fiorino, G., Peyrin‐Biroulet, L., Danese, S., et al. (2024) · Microorganisms · doi:10.3390/microorganisms12091755 · Cited by 49

Management of paediatric ulcerative colitis, part 1: Ambulatory care—An updated evidence‐based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation

Wine, E., Aloi, M., Biervliet, S. V., Bronský, J., de Carpi, J. M., Gasparetto, M., Gianolio, L., Gordon, H., Hojsak, I., Hudson, A. S., et al. (2025) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/jpn3.70097 · Cited by 52

Dietary Exposures and Interventions in Inflammatory Bowel Disease: Current Evidence and Emerging Concepts

Gubatan, J. M. B., Kulkarni, C. V., Talamantes, S., Temby, M., Fardeen, T., & Sinha, S. R. (2023) · Nutrients · doi:10.3390/nu15030579 · Cited by 45

Fecal microbiota transplantation for the maintenance of remission in patients with ulcerative colitis: A randomized controlled trial

Lahtinen, P., Jalanka, J., Mattila, E. J., Tillonen, J., Bergman, P., Satokari, R. M., & Arkkila, P. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i17.2666 · Cited by 45

Gut microbiome dysbiosis in inflammatory bowel disease

Lal, S., Kandiyal, B., Ahuja, V., Takeda, K., & Das, B. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.09.003 · Cited by 43

Rigorous Donor Selection for Fecal Microbiota Transplantation in Active Ulcerative Colitis: Key Lessons From a Randomized Controlled Trial Halted for Futility

Caenepeel, C., Deleu, S., Vázquez-Castellanos, J. F., Arnauts, K., Braekeleire, S., Machiels, K., Baert, F., Mana, F., Pouillon, L., Hindryckx, P., et al. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.05.017 · Cited by 43

Diet and Microbiome-Directed Therapy 2.0 for IBD

Ananthakrishnan, A. N., Whelan, K., Allegretti, J. R., & Sokol, H. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.05.049 · Cited by 43

Microbiota-mediated mechanisms of mucosal immunity across the lifespan

Iliev, I. D., Blander, J. M., Collins, N., Guo, C., Longman, R., Sonnenberg, G. F., Zeng, M. Y., & Artis, D. (2025) · Nature Immunology · doi:10.1038/s41590-025-02281-w · Cited by 55

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

Mullish, B. H., Merrick, B., Quraishi, M. N., Bak, A., Green, C., Moore, D., Porter, R. J., Elumogo, N., Segal, J. P., Sharma, N., et al. (2024) · Journal of Hospital Infection · doi:10.1016/j.jhin.2024.03.001 · Cited by 42

Gut bacteriome in inflammatory bowel disease: An update on recent advances

Bajaj, A., Markandey, M., Kedia, S., & Ahuja, V. (2024) · Indian Journal of Gastroenterology · doi:10.1007/s12664-024-01541-1 · Cited by 42

The Role of Gut Microbiota in Gastrointestinal Immune Homeostasis and Inflammation: Implications for Inflammatory Bowel Disease

Bretto, E., Caviglia, G. P., Saracco, G. M., Bugianesi, E., & Ribaldone, D. G. (2025) · Biomedicines · doi:10.3390/biomedicines13081807 · Cited by 41

The Key Nutrients in the Mediterranean Diet and Their Effects in Inflammatory Bowel Disease: A Narrative Review

Deleu, S., Becherucci, G., Godny, L., Mentella, M. C., Petito, V., & Scaldaferri, F. (2024) · Nutrients · doi:10.3390/nu16234201 · Cited by 37

Fecal microbiota transplantation: application scenarios, efficacy prediction, and factors impacting donor-recipient interplay

Liu, Y., Li, X., Chen, Y., Yao, Q., Zhou, J., Wang, X., Meng, Q., Ji, J., Yu, Z., & Chen, X. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1556827 · Cited by 37

Loss of claudin-3 expression increases colitis risk by promoting Gut Dysbiosis

Ahmad, R., Kumar, B., Thapa, I., Talmon, G. A., Salomon, J., Ramer‐Tait, A. E., Bastola, D. K., Dhawan, P., & Singh, A. B. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2282789 · Cited by 36

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

Mullish, B. H., Merrick, B., Quraishi, M. N., Bak, A., Green, C., Moore, D., Porter, R. J., Elumogo, N., Segal, J. P., Sharma, N., et al. (2024) · Gut · doi:10.1136/gutjnl-2023-331550 · Cited by 40

Holistic healthcare in inflammatory bowel disease: time for patient-centric approaches?

Sudhakar, P., Wellens, J., Verstockt, B., Ferrante, M., Sabino, J., & Vermeire, S. (2022) · Gut · doi:10.1136/gutjnl-2022-328221 · Cited by 35

The Progression of Microbiome Therapeutics for the Management of Gastrointestinal Diseases and Beyond

Allegretti, J. R., Khanna, S., Mullish, B. H., & Feuerstadt, P. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.05.004 · Cited by 35

Western diet influences on microbiome and carcinogenesis

Newsome, R. C., Yang, Y., & Jobin, C. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101756 · Cited by 35

Preliminary Results From a Multicenter, Randomized Trial Using Fecal Microbiota Transplantation to Induce Remission in Patients With Mild-to-Moderate Crohn's Disease

Kao, D. H., Wong, K., Jijon, H. B., Moayyedi, P., Franz, R., McDougall, C., Hotte, N., Panaccione, R., Semlacher, E. A., Kroeker, K. I., et al. (2024) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003196 · Cited by 32

Anaerobic Feces Processing for Fecal Microbiota Transplantation Improves Viability of Obligate Anaerobes

Bénard, M. V., Arretxe, I., Wortelboer, K., Harmsen, H. J. M., Davids, M., de Bruijn, C. M. A., Benninga, M. A., Hugenholtz, F., Herrema, H., & Ponsioen, C. Y. (2023) · Microorganisms · doi:10.3390/microorganisms11092238 · Cited by 32

Targeting the gut microbiota in inflammatory bowel diseases: where are we?

Benech, N., & Sokol, H. (2023) · Current Opinion in Microbiology · doi:10.1016/j.mib.2023.102319 · Cited by 31

Lactobacillus fermentum 016 Alleviates Mice Colitis by Modulating Oxidative Stress, Gut Microbiota, and Microbial Metabolism

Pan, H., Yang, S., Kulyar, M. F., Ma, H., Li, K., Zhang, L., Mo, Q., & Li, J. (2025) · Nutrients · doi:10.3390/nu17030452 · Cited by 34

MicroRNA‐Enriched Plant‐Derived Exosomes Alleviate Colitis by Modulating Systemic Immunity, Metabolic Homeostasis, and Gut Microbiota

Shi, R., Tan, W., Jin, H., Chan, S. I., Li, W., Lei, S. S., Cui, G., Wang, Y., Yang, D., & Zhong, Z. (2025) · Advanced Science · doi:10.1002/advs.202505921 · Cited by 30

The practice of fecal microbiota transplantation in inflammatory bowel disease

Arora, U., Kedia, S., & Ahuja, V. (2023) · Intestinal Research · doi:10.5217/ir.2023.00085 · Cited by 32

New targets for the treatment of ulcerative colitis: Gut microbiota and its metabolites

Li, H., Pan, M., Li, Y., Cui, M., & Zhang, M. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.05.006 · Cited by 29

Oral delivery of sodium alginate/chitosan bilayer microgels loaded with Lactobacillus rhamnosus GG for targeted therapy of ulcerative colitis

Hu, Y., Zhu, S., Ye, X., Wen, Z., Fu, H., Zhao, J., Zhao, M., Li, X., Wang, Y., Li, X., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134785 · Cited by 28

Gut Microbiota Features in Relation to Fecal Microbiota Transplantation Outcome in Ulcerative Colitis: A Systematic Review and Meta-Analysis

Bénard, M. V., de Goffau, M. C., Blonk, J., Hugenholtz, F., van Buuren, J., Paramsothy, S., Kaakoush, N. O., D’Haens, G., Borody, T. J., Kamm, M. A., et al. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.10.001 · Cited by 28

Tryptophan metabolism and the intestinal microbiota: Implications for inflammatory bowel disease.

Hua, X., Chen, Y.-C., Ding, S.-J., & Fang, J. (2025) · Microbiology Research · doi:10.1016/j.micres.2025.128280 · Cited by 29

Challenges in IBD Research 2024: Environmental Triggers

Ananthakrishnan, A. N., Gerasimidis, K., Ho, S., Mayer, E. A., Pollock, J. S., Soni, S., Wu, G. D., Benyacoub, J., Ali, B., Favreau, A., et al. (2024) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izae085 · Cited by 27

Interaction Between Microbiota and Immunity: Molecular Mechanisms, Biological Functions, Diseases, and New Therapeutic Opportunities

Zeng, J., He, Z., Wang, G., Ma, Y., & Zhang, F. (2025) · MedComm · doi:10.1002/mco2.70265 · Cited by 29

The role of faecal microbiota transplantation in chronic noncommunicable disorders

Mullish, B. H., Tohumcu, E., Porcari, S., Fiorani, M., Tommaso, N. D., Gasbarrini, A., Cammarota, G., Ponziani, F. R., & Ianiro, G. (2023) · Journal of Autoimmunity · doi:10.1016/j.jaut.2023.103034 · Cited by 25

Strategies and opportunities of micro/nano delivery systems for targeted therapy of ulcerative colitis: Focus on underlying mechanisms and future perspectives

Liu, Z., Liu, H., Cheng, J., Wang, H., Yang, Y., Ye, J., & Liu, Y. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2023.109074 · Cited by 26

Meta-analysis of the human gut microbiome uncovers shared and distinct microbial signatures between diseases

Jin, D.-M., Morton, J. T., & Bonneau, R. (2024) · mSystems · doi:10.1128/msystems.00295-24 · Cited by 27

Autoimmune diseases and gut microbiota: a bibliometric and visual analysis from 2004 to 2022

Zhang, Y., Peng, Y., & Xu, X. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01028-x · Cited by 25

A history of repeated antibiotic usage leads to microbiota-dependent mucus defects

Krigul, K. L., Feeney, R. H., Wongkuna, S., Aasmets, O., Holmberg, S. M., Andreson, R., Puértolas-Balint, F., Pantiukh, K., Sootak, L., Org, T., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2377570 · Cited by 25

Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference

Lopetuso, L. R., Deleu, S., Puca, P., Abreu, M. T., Armuzzi, A., Barbara, G., Caprioli, F., Ng, S. C., Costello, S. P., Damiani, A., et al. (2025) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaf013 · Cited by 23

Microbiota dysbiosis and myasthenia gravis: Do all roads lead to Rome?

Kapoor, B., Gulati, M., Gupta, R., & Singla, R. K. (2023) · Autoimmunity Reviews · doi:10.1016/j.autrev.2023.103313 · Cited by 25

Preferred Reporting Items for Microbiotherapy (PRIM) Guidelines Across Medical Disciplines: An International Delphi Consensus

Zhang, F., Kamm, M. A., Wu, X., Kao, D. H., Borody, T. J., Chen, L. A., He, X., Fischer, M., Wong, S. H., Ng, S. C., et al. (2025) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16947 · Cited by 23

Role of diet in prevention versus treatment of Crohn’s disease and ulcerative colitis

Halmos, E. P., Godny, L., Vanderstappen, J., Shabat, C. S., & Svolos, V. (2024) · Frontline Gastroenterology · doi:10.1136/flgastro-2023-102417 · Cited by 22

Donor composition and fiber promote strain engraftment in a randomized controlled trial of fecal microbiota transplant for ulcerative colitis

Gogokhia, L., Tran, N., Grier, A., Nagayama, M., Xiang, G., Funez-dePagnier, G., Lavergne, A., Ericsson, C., Maamar, S. B., Zhang, M., et al. (2025) · Med · doi:10.1016/j.medj.2025.100707 · Cited by 22

Gut microbiome in IBD: past, present and the future

Zhang, J., Mak, J. W. Y., & Ng, S. C. (2025) · Gut · doi:10.1136/gutjnl-2025-335626 · Cited by 22

Review article: Evidence‐based dietary management of inflammatory bowel disease

Gibson, P. R., Yao, C. K., & Halmos, E. P. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.18214 · Cited by 24

Current perspectives on fecal microbiota transplantation in inflammatory bowel disease

Singh, A., Midha, V., Chauhan, N. S., & Sood, A. (2024) · Indian Journal of Gastroenterology · doi:10.1007/s12664-023-01516-8 · Cited by 20

Revolution in diet therapy for inflammatory bowel disease

Melton, S. L., Day, A. S., Bryant, R. V., & Halmos, E. P. (2024) · JGH Open · doi:10.1002/jgh3.13097 · Cited by 20

Ulcerative Colitis: Advances in Pathogenesis, Biomarkers, and Therapeutic Strategies

Bu, S., Xu, C., Chen, M., & Yu, Y. (2025) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s536459 · Cited by 19

Emerging microbiome-directed therapies in inflammatory bowel disease: beyond diet modification and FMT

Centeno, A., Atanasova, K., Ebert, M. P., Thomann, A., & Reindl, W. (2025) · Seminars in Immunopathology · doi:10.1007/s00281-025-01066-5 · Cited by 21

What Should I Eat? Dietary Recommendations for Patients with Inflammatory Bowel Disease

Saha, S., & Patel, N. (2023) · Nutrients · doi:10.3390/nu15040896 · Cited by 19

The Role of the Gut Microbiome in Health and Disease in the Elderly

Chen, L. A., & Boyle, K. (2024) · Current Gastroenterology Reports · doi:10.1007/s11894-024-00932-w · Cited by 22

Inflammatory bowel disease in south Asia: a scoping review

Shenoy, S., Jena, A., Levinson, C., Sharma, V., Deepak, P., Aswani-Omprakash, T., Sebastian, S., Colombel, J., & Agrawal, M. (2025) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(24)00341-8 · Cited by 19

Soil organic carbon mediates plant immunity-rhizosphere microbiome interactions and controls colonization resistance to microbial inoculants

Huang, Y., Tang, S., Liu, R., Yu, P., Liu, J., Xiao, T., Zhang, Y., Fan, M., Zhang, F. S., & Ni, B. (2025) · Cell Host & Microbe · doi:10.1016/j.chom.2025.10.002 · Cited by 18

Fecal microbiota transplantation in autoimmune diseases – An extensive paper on a pathogenetic therapy

Seida, I., Shawaf, M. A., & Mahroum, N. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103541 · Cited by 17

Dietary content and eating behavior in ulcerative colitis: a narrative review and future perspective

Qin, L., & Lv, W. (2025) · Nutrition Journal · doi:10.1186/s12937-025-01075-y · Cited by 17

Effectiveness of Partial Enteral Nutrition as Add-On to Biologics in Patients With Refractory and Difficult-to-Treat Crohn’s Disease: A Pilot Study

Nardone, O. M., Calabrese, G., Mantia, A. L., Testa, A., Rispo, A., Alfonsi, L., Pasanisi, F., & Castiglione, F. (2024) · Crohn s & Colitis 360 · doi:10.1093/crocol/otae011 · Cited by 16

Gut bacteria: an etiological agent in human pathological conditions

Islam, M. M., Mahbub, N. U., Hong, S., & Chung, H. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1291148 · Cited by 18

Fecal microbiota transplantation refurbishes the crypt-associated microbiota in ulcerative colitis

Markandey, M., Bajaj, A., Verma, M., Virmani, S., Singh, M. K., Gaur, P., Das, P., Srikanth, C. V., Makharia, G. K., Kedia, S., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106738 · Cited by 15

The Impacts of Fecal Microbiota Transplantation from Same Sex on the Symptoms of Ulcerative Colitis Patients

Shang, S., Zhu, J., Liu, X., Wang, W., Dai, T., Wang, L., & Li, B. (2023) · Polish Journal of Microbiology · doi:10.33073/pjm-2023-025 · Cited by 15

Mucosal Immunity to Gut Fungi in Health and Inflammatory Bowel Disease

Carlson, S. L., Mathew, L., Savage, M., Kok, K. B., Lindsay, J. O., Munro, C. A., & McCarthy, N. E. (2023) · Journal of Fungi · doi:10.3390/jof9111105 · Cited by 17

Coconut Water Induces Clinical Remission in Mild to Moderate Ulcerative Colitis: Double-blind Placebo-controlled Trial

Kedia, S., Virmani, S., Bajaj, A., Markandey, M., Singh, N., Madan, D., Kaushal, K., Sahu, P., Vuyyuru, S. K., Kante, B., et al. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.01.013 · Cited by 16

Principles and Practice Guidelines of Microbiota Medicine: Statements From the CHINAGUT Conference

Zhang, F., Pi, Z., Wong, H. S., Ahuja, V., Porcari, S., Ishikawa, D., Cao, H., Chen, L., Chen, N., Chen, X., et al. (2026) · Microbiota Medicine Research · doi:10.1002/mmr3.70001 · Cited by 15

Microbiota transplant therapy in inflammatory bowel disease: advances and mechanistic insights

Moutsoglou, D., Ramakrishnan, P., & Vaughn, B. P. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2477255 · Cited by 14

Fecal microbiota transplantation-current perspective on human health

Cao, Z., Gao, T., Bajinka, O., Zhang, Y., & Yuan, X. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1523870 · Cited by 14

The role of the three major intestinal barriers in ulcerative colitis in the elderly

Fu, M., Wang, Q.-W., Liu, Y., & Chen, S. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102752 · Cited by 14

Recent progresses in gut microbiome mediates obstructive sleep apnea‐induced cardiovascular diseases

Zhang, X., Zhang, H., Li, S. C., Fang, F., Yin, Y., & Wang, Q. (2024) · FASEB BioAdvances · doi:10.1096/fba.2023-00153 · Cited by 13

Fecal microbiota transplantation for the treatment of intestinal and extra‐intestinal diseases: Mechanism basis, clinical application, and potential prospect

Yi, D., Li, T., Xiao, Y., Zhang, X., Hao, Q., Zhang, F., Qiu, T., Yang, G., Sun, X., Dong, Y., et al. (2024) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10728 · Cited by 14

Therapy Used to Promote Disease Remission Targeting Gut Dysbiosis, in UC Patients with Active Disease

Mirsepasi‐Lauridsen, H. C. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11247472 · Cited by 13

Microbiome and Diet in Colon Cancer Development and Treatment

Kato, I., & Sun, J. (2023) · The Cancer Journal · doi:10.1097/ppo.0000000000000649 · Cited by 14

Take-Home Messages from 20 Years of Progress in Dietary Therapy of Inflammatory Bowel Disease

Gkikas, K., Svolos, V., Hansen, R., Russell, R. K., & Gerasimidis, K. (2023) · Annals of Nutrition and Metabolism · doi:10.1159/000535007 · Cited by 13

L-theanine prevents ulcerative colitis by regulating the CD4+ T cell immune response through the gut microbiota and its metabolites

Xu, W., Liu, A.-X., Gong, Z., & Xiao, W. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.109845 · Cited by 12

Investigating the Crime Scene—Molecular Signatures in Inflammatory Bowel Disease

Andersen, V. C., Bennike, T. B., Bang, C., Rioux, J. D., Hébert-Milette, I., Sato, T., Hansen, A. K., & Nielsen, O. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311217 · Cited by 12

The 2023 Impact of Inflammatory Bowel Disease in Canada: Treatment Landscape

Murthy, S. K., Weizman, A. V., Kuenzig, M. E., Windsor, J. W., Kaplan, G. G., Benchimol, E. I., Bernstein, C. N., Bitton, A., Coward, S. B., Jones, J., et al. (2023) · Journal of the Canadian Association of Gastroenterology · doi:10.1093/jcag/gwad015 · Cited by 12

Dental problems and oral microbiome alterations in ulcerative colitis

Kucharski, R., Sobocki, B. K., Stachowska, E., Bulman, N., Kalinowski, L., & Kaźmierczak-Siedlecka, K. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1502605 · Cited by 12

Fufangxiaopi formula alleviates DSS-induced colitis in mice by inhibiting inflammatory reaction, protecting intestinal barrier and regulating intestinal microecology

Liu, K., Shi, C., Yan, C., Yin, Y., Qiu, L., He, S., Chen, W., & Li, G. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117365 · Cited by 12

Intestinal microecology dysbiosis in inflammatory bowel disease: Pathogenesis and therapeutic strategies

Yin, Y., Feng, W., Chen, X., Chen, J., Wang, G., Xia, L., & Wu, K. (2024) · The Innovation Medicine · doi:10.59717/j.xinn-med.2024.100092 · Cited by 11

Nutritional optimization of fecal microbiota transplantation in humans: a scoping review

Teigen, L. M., Hoeg, A., Zehra, H., Shah, P., Johnson, R., Hutchison, K., Kocher, M., Lin, A., Johnson, A. J., & Vaughn, B. P. (2025) · Gut Microbes · doi:10.1080/19490976.2024.2446378 · Cited by 11

Restoration of Mucosal and Fecal Microbiome, Mycobiome and Metabolome is Associated with Response to Fecal Microbiota Transplantation and Anti-Inflammatory Diet in Active Ulcerative ColitisPreprint

Markandey, M., Bajaj, A., Kshetrapal, P., Virmani, S., Singh, M., Verma, M., Ramasamy, T., Vuyyuru, S. K., Kante, B., Kumar, P., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4953224

IDDF2018-ABS-0220 Faecal microbiota transplantation for maintenance of clinical remission in patients with active ulcerative colitis: a randomised control trial

Mahajan, R., Midha, V., Mehta, V., Singh, A., Khattar, H., Narang, V., & Sood, A. (2018) · Clinical Gastroenterology · doi:10.1136/gutjnl-2018-iddfbestabstracts.15 · Cited by 2

Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial

Moayyedi, P., Surette, M. G., Kim, P. T., Libertucci, J., Wolfe, M., Onischi, C., Armstrong, D., Marshall, J. K., Kassam, Z., Reinisch, W., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.001 · Cited by 1,499

S1705 Diet Modulation in Conjunction With Fecal Microbiota Transplantation for Refractory Ulcerative Colitis: A Systematic Review of Emerging Strategies and Clinical Outcomes

Kattela, S., Nekkanti, S. K., Bhatt, H. M., Gohil, N., Golakiya, I. A., Das, S., Saifuddin, M., Marlecha, P., Palakurthi, A., & Younas, S. (2025) · The American Journal of Gastroenterology · doi:10.14309/01.ajg.0001134280.87056.0a

DOP07 Long-term results of 4.5 years of faecal microbiota transplantation for treatment of refractory ulcerative colitis

Uygun, A., Karakaya, M. F., ERDAL, H., Celebi, G., Sakın, Y. S., Artuk, C., Öztürk, K., & Gulsen, M. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz203.046